Position in SGMOQ
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$1,500
-$11,640 QoQ
Shares Held
6,000
-83.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in SGMOQ Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NFSG Corp holds $2,875,353 across 46 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
3,061 | $1,643,603 | |
| 2 | OMER |
Omeros Corp
|
46,210 | $439,457 | |
| 3 | NTLA |
Intellia Therapeutics, Inc.
|
11,925 | $201,771 | |
| 4 | CORT |
Corcept Therapeutics Inc
|
1,003 | $87,210 | |
| 5 | VKTX |
Viking Therapeutics, Inc.
|
1,700 | $66,317 | |
| 6 | GLSI |
Greenwich LifeSciences, Inc.
|
2,100 | $49,266 | |
| 7 | VERA |
Vera Therapeutics, Inc.
|
1,000 | $42,910 | |
| 8 | PALI |
Palisade Bio, Inc.
|
20,250 | $42,322 |
All Filings in SGMOQ
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,500 | 6,000 | Shares | Sole | 2026-05-05 | |
| 2024-06-30 | $13,140 | 36,500 | Shares | Sole | 2024-09-11 | |
| 2024-03-31 | $24,455 | 36,500 | Shares | Sole | 2024-04-24 | |
| 2022-12-31 | $6,280 | 2,000 | Shares | Sole | 2023-01-17 | |
| 2022-09-30 | $9,800 | 2,000 | Shares | Sole | 2022-10-13 | |
| 2022-06-30 | $12,420 | 3,000 | Shares | Sole | 2022-07-15 | |
| 2022-03-31 | $8,715 | 1,500 | Shares | Sole | 2022-04-26 | |
| 2021-12-31 | $11,250 | 1,500 | Shares | Sole | 2022-01-19 | |
| 2021-09-30 | $13,515 | 1,500 | Shares | Sole | 2021-10-27 | |
| No filing history on record for this holder in this stock. | ||||||